Shock waves may ease lower cross syndrome pain
NCT ID NCT06531746
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested whether extracorporeal shock wave therapy could reduce pain and improve muscle activity in 40 adults with Lower Cross Syndrome, a condition of muscle imbalance. Participants received either real shock waves, a standard physical therapy program, or a sham treatment. The main goals were to measure pain levels and electrical activity in the lower back muscles.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- extracorporeal shock wave therapy
- What this could lead to
- If it works, this could offer a non-drug option to ease pain and improve muscle function in people with Lower Cross Syndrome.
- What could go wrong
- This is a small, completed trial with only 40 participants, so results may not apply to everyone. The sham group received no real treatment, which limits comparison.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 45 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Forty-four lower cross syndrome patients from both genders their ages ranged from 30-45 years old. 2. All patients in present study will be ambulant independently. 3. All patients will be medically stable. 4. The body mass index (BMI) will be ranged from 20:25 Kg/m2. Exclusion Criteria: 1. Patients with musculoskeletal deformities and disorders. 2. Patients with psychiatric disorders or seizures. 3. Patients with visual and auditory impairment or tremors influencing balance. 4. Patients with other neuromuscular disorders. 5. Patients with BMI more than 25 kg/m2. 6. Patients with cognitive impairment. 7. Patients with lower limb or head and brain surgeries.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lower cross syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al Ryada University for Science and Technology
Sadat, Menoufia, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.